A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)
Clinical trial NCT04530994 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04530994
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.